The US health agency has come close to simply warning about the risk of blood clots from Johnson & Johnson’s
People familiar with the matter said the COVID-19 vaccine had decided to suspend use because of concerns that doctors would improperly treat the condition.
For the previous four weeks, US health officials were alerted to a similar clotting situation in Europe related to AstraZeneca PLC’s COVID-19 vaccine.
people said. Officials have dug into the US vaccine safety database and identified troubling cases, but are still debating what action should be taken.
By Monday night, officials had resolved that urgent action was needed, residents said. According to the US Centers for Disease Control and Prevention, four out of six women in the US who developed a blood clot a few days after the initial vaccination had been injected with heparin. These people said its use could make the patient’s condition worse.
On that night, the country’s top health officials agreed during an hour-long meeting with Zoom to take the strongest step: recommending publicly suspending the use of vaccines during testing of the side effects, people said.
Since the announcement, the Food and Drug Administration has studied other reports of additional blood clotting cases in J&J vaccinated people, but has not confirmed whether there is any reflection of the phenomenon. similar or not, people said. Officials are increasingly convinced that a total of six reported cases so far were related to the shooting, residents added.
Also popular on WSJ.com: